The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

Thu, 04th Jan 2024 10:43

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Angle PLC, up 62% at 21.50 pence, 12-month range 9.07p-48.50p. Shares in the medical diagnostics firm soar after it unveils "breakthrough" clinical results from DNA molecular analysis of cancer patient blood samples that "provide a unique insight into the progression of each patient's cancer and how this may be treated". Angle says the results "highlight the potential for the Parsortix system to identify key variants [of] DNA mutations missed by other approaches to help guide treatment decisions." Chief Executive Officer Andrew Newland says: "Today's breakthrough is the critical next step post the [US Food & Drug Administration] clearance to show in a sample-to-answer format the potential clinical value of [next generation sequencing] molecular analysis on a repeat basis of living cancer cells harvested from patient blood samples. Angle is committed to delivering transformational benefits to cancer patients through a simple blood test. This is a major step in this process."

----------

Likewise Group PLC, up 15% at 23.00p, 12-month range 14.00p-28.00p. The domestic and commercial floor coverings distributor says 2023 gross sales revenue rose 14% to GBP140.2 million from a year earlier, while sales in Likewise Floors rose 29%. It says these increases are "particularly positive given the macro economic headwinds and subsequent challenging market conditions". Likewise says 2023 sales revenue is ahead of current market expectations and underlying profitability is expected to be in line with market expectations, reflecting the continued investment in the future of the business. Looking ahead, it is confident of achieving current market expectations for 2024, as it "continues to develop its position in the UK flooring market".

----------

AIM - LOSERS

----------

Landore Resources Ltd, down 13% at 2.70p, 12-month range 2.33p-18.37p. The Ontario, Canada-focused precious and base metal project explorer and developer raises GBP600,000 via a placing and subscription of 25.0 million new shares at a price of 2.4p each. The net proceeds of the fundraising will be used for general working capital purposes and to progress its strategy towards advancing its flagship BAM gold project at the Junior Lake property in northwestern Ontario. It says the new shares represent around 17% of its enlarged share capital. Landore also says Chief Executive Officer Claude Lemasson resigns with immediate effect, with Glenn Featherby assuming the role of interim CEO.

----------

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 10:52

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

3 May 2024 08:48

LONDON MARKET OPEN: Confident start before US jobs data

(Alliance News) - Stock prices in London opened higher on Friday, on the rising conviction that the afternoon's US jobs report will be softer, cooling...

3 May 2024 07:58

Angle strikes supplier deal with AstraZeneca

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen recepto...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.